Is equitable priority vaccination of vulnerable people feasible in a real-world context? The case of Belgium

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Belgium has implemented a strategy to prioritize vaccination at population level during the COVID-19 pandemic, targeting individuals with pre-existing health conditions at increased risk of severe COVID-19. We aimed to evaluate whether prioritized groups were vaccinated sooner, and which socio-demographic and -economic characteristics were related to the speed of vaccine uptake. We calculated the time to vaccination between the start of the prioritization (1 April 2021) and receiving a first COVID-19 vaccine dose, using this interval as a proxy for evaluating the strategy's early impact. A multivariate regression model, incorporating priority status, age, sex, region of residence, income, and migration background, described the natural logarithm of this time gap. The sample included 4 472 873 individuals vaccinated between 1 April and 31 December 2021, of which 26.4% were prioritized. The results show a 34.6 days earlier vaccination for prioritized individuals versus non-prioritized ones. The time difference between the prioritized and non-prioritized groups was larger in the younger age groups compared to the older age groups (28.2 days versus 19.3 days). Based on the multivariate model estimates, being prioritized [ priority -0.37, 95% CI (-0.38; -0.36)], older age [ 55- 64 -0.57, 95% CI(-0.58; -0.56)], residency in Brussels or Wallonia [ Brussels -0.18, 95%CI (-0.20; -0.16); Wallonia -0.18, 95% CI (-0.19; -0.17)], having a high income [ high income -0.11, 95% CI (-0.12; -0.10)], being a Belgian national ( belgian reference), having had a recent prior infection ( no prior infection reference) and being female ( female reference) are associated with a shorter time to vaccination. Developing and implementing a prioritization vaccination strategy accelerated vaccination for the high-risk population with health conditions, demonstrating its feasibility in promoting equitable access to COVID-19 vaccines.

Cite

CITATION STYLE

APA

Vermeiren, E., Scheerens, C., Stouten, V., Crombez, J., De Maeseneer, J., & Van Loenhout, J. A. F. (2025). Is equitable priority vaccination of vulnerable people feasible in a real-world context? The case of Belgium. European Journal of Public Health, 35(4), 774–780. https://doi.org/10.1093/eurpub/ckaf075

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free